Costello Asset Management’s Gilead Sciences GILD Stock Holding History

Costello Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Buy	725 +300	+71%	+$42K	0.03%	166
2025 Q4	$52.2K	Buy	425 +25	+6%	+$3.04K	0.02%	218
2025 Q3	$44.4K	Buy	400 +80	+25%	+$9.09K	0.01%	256
2025 Q2	$35.5K	Buy	320 +227	+244%	+$24.2K	0.01%	285
2025 Q1	$10.4K	Buy	+93	New	+$9.6K	﹤0.01%	450
2021 Q4	–	Sell	-125	Closed	-$9K	–	242
2021 Q3	$9K	Sell	125 -25	-17%	-$1.76K	0.01%	177
2021 Q2	$10K	Hold	150	–	–	0.01%	177
2021 Q1	$10K	Hold	150	–	–	0.01%	193
2020 Q4	$9K	Hold	150	–	–	0.01%	183
2020 Q3	$9K	Buy	+150	New	+$10.4K	0.01%	166

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Costello Asset Management's GILD Position: Q1 2026 in Review

Costello Asset Management increased its Gilead Sciences (GILD) stake by 71% in Q1 2026, buying an estimated $42K and bringing the position to 725 shares worth $101K. The position accounts for 0.03% of the portfolio, ranked #166.

Costello Asset Management first reported a position in GILD in Q3 2020 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Costello Asset Management held 725 shares of Gilead Sciences worth $101K as of Q1 2026.
Costello Asset Management bought 300 Gilead Sciences shares in Q1 2026, an estimated $42K.
Gilead Sciences made up 0.03% of Costello Asset Management's portfolio in Q1 2026, its #166 holding.
Costello Asset Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Costello Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.